| Novartis Pharma Schweiz AG - Pluvicto CA 1000 MBq/ml, Injektions-/Infusionslösung |
| 69027 | | 01 | | Pluvicto CA 1000 MBq/ml | | Injektions-/Infusionslösung | | V10XX05 | | Lutetium (177lu) Vipivotide Tetraxetan | | 24.02.2023 | | |
|
| Composition |
| lutetium(177-Lu(CA)) vipivotidum tetraxetanum 1000 MBq, acidum aceticum, natrii acetas, acidum gentisicum, natrii ascorbas, acidum penteticum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 7.1 mg. |
| Packungsbestandteile |
| Infusion solution | | | | | | Active Agent | Dose |
|---|
| Lutetium(177lu(Ca)) Vipivotidum Tetraxetanum | 1000 MBq/ml |
| | | | Inactive agents |
|---|
| Acetic Acid | | Acidum Gentisicum | | Acidum Penteticum | | Sodium Acetate | | Sodium Ascorbate |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | A | | No |
|
